Halberd Corporation (@HalberdC) header
Halberd Corporation (@HalberdC) profile picture

HALB on OTC has 3 patents and 22 pending. Eradicates diseases from bodily fluids; focusing on PTSD, Depression, Addiction, neurodegenerative diseases & Cancer.

Joined June 2020
Back under the hood at Neurosense: Every check-in stored per subject — longitudinal monitoring in the database layer. #DigitalHealth #HealthTech #Halberd
1
1
511
$HALB Under the hood at NeuroSense: our Composite Stress Index weights 5 vocal biomarkers into a single 0–100 score — built for longitudinal monitoring, alerts, and AI-assisted clinical insight. Prototype → product. #DigitalHealth #HealthTech #AI
1
1
1
6
1,755
$HALB Halberd’s Patented Drug, LDN+, the Subject of a Limited Clinical Trial under an Innovative Four-company Cooperative Research and Development (CRADA) Contract. bit.ly/4aKjm3Y
1
7
6
23
1,299
$HALB Halberd Corp updated their OTC Markets profile to reflect technology products with most promising near-term market introductions.
4
6
6
19
2,452
$HALB 2023 Year-End CEO Update and 2024 Goals 👉 bit.ly/47xEPuQ
5
1
1
12
1,140
$HALB continuing applications for government contracts with counsel from experienced contract winner, Athena GTX. #halberd #athenagtx #BreakingNews
7
3
3
13
3,918
$HALB Hartman, CEO and Dr. Felder, CTO of Halberd Corp Featured on The Street Reports Podcast bit.ly/45oDaqG bit.ly/3tr3WRM
3
3
12
2,668
$HALB Traumatic Brain Injury (TBI) Testing Results Replicated at Mississippi State University (MSU) halberdcorporation.com/halbe… #BreakingNews #Halberd #MSU
2
1
7
17
2,555
$HALB Astounding Early Test Results of Halberd’s Traumatic Brain Injury (TBI) Project at Mississippi State University (MSU) bit.ly/3Lbb0rM
2
8
6
24
2,135
$HALB Halberd’s Successful Completion of Sampling Phase Marks Major Milestone for Project at Mississippi State University (MSU) bit.ly/3KQvS7s #BreakingNews #StayInformed #Halberd
7
4
14
2,812
$HALB Halberd-Mississippi State University (MSU) Testing of TBI Nasal Spray Progresses bit.ly/444TnAt
8
2
4
15
1,539
$HALB Key 2nd Q Achievements: 1. MSU tests brain injury nasal spray. 2. Eradication antibiotic-resistant Candida Auris. 3. YSU achieves laser eradication success. 4. Halberd submits NIH abstracts. 5. Disease-specific funding submitted. More to Come... finance.yahoo.com/news/halbe…
10
5
9
30
4,036
$HALB patent-pending portable nasal spray test program at Mississippi State University (MSU) is on track to measure effectiveness in stopping progression of brain damage following head trauma in multiple test subjects, varying for the testing groups (non-control subjects):
13
10
4
24
2,452
$HALB Testing of Nasal Spray to Counteract the Effects of Head Trauma to Begin by Month End https://nitter.cf/t.co/y8OrSOkDDL
2
5
6
20
1,660
$HALB Halberd Corporation 1Q23 CEO Letter The first quarter 2023 continued this extraordinarily groundbreaking path, packed with new accomplishments. 👉https://nitter.cf/t.co/Mwv0e7Yrzz
5
6
3
24
1,874
$HALB Halberd and #YSU Interviewed on CBS Affiliate #WKBN 5pm News as Research Advances ➡️https://nitter.cf/t.co/dZSFINWUFQ
5
3
24
1,215
$HALB Halberd Begins Preclinical Testing at Mississippi State University (MSU) https://nitter.cf/t.co/T1zgAvtzr7 #MSU #Halberd
2
10
6
26
3,448
$HALB is developing a series of abstracts covering patented and patent-pending technologies for submission to ARPA-H, the government group that funds new medical-related technologies. #arpah #halberd
5
13
9
30
3,094